Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X - Wikidata - awgldk - TriplyDB

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

http://www.wikidata.org/entity/Q27632583

about

Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2 ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus)The linker connecting the two kringles plays a key role in prothrombin activation Crystal structures of carbohydrate recognition domain of blood dendritic cell antigen-2 (BDCA2) reveal a common domain-swapped dimer Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom.Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks Anticoagulant proteins from snake venoms: structure, function and mechanism Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.Capturing spontaneous partitioning of peripheral proteins using a biphasic membrane-mimetic model.Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography.Efficient Exploration of Membrane-Associated Phenomena at Atomic Resolution.Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6.Snake venoms and hemostasis.Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis.Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome.Toxins in thrombosis and haemostasis: potential beyond imagination.Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop.Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively.Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X.The role of Ca(2+) ions in the complex assembling of protein Z and Z-dependent protease inhibitor: A structure and dynamics investigation.Sphingolipids as bioactive regulators of thrombin generation.Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparin.Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2.Lipid specificity of the membrane binding domain of coagulation factor X.

P2860

Q24304876-5C269B47-1664-43C9-8B74-9902739622E3 Q24657449-BDBD5AAF-411B-40F2-A057-3C006CAE3F7B Q26747656-C91A2158-6C08-443D-B590-4994304684BD Q27640988-7C29DE1F-DD22-4FB9-AD2D-CFC6C6D7ED2F Q27641649-49CD35DC-6EDB-4FAA-8F32-E2F81DAE09F7 Q27642529-0F4DBD65-5FDC-4A48-905E-44DEF71508D2 Q27683765-DFFBB54E-4CA5-4B0B-917F-B2E5C6B840A8 Q27688898-1B8FE406-07AB-4587-A042-7F80417966AE Q28075348-50DE044A-3EB4-4E59-8FDB-93546F07521C Q33350605-E32E0B0F-722D-4162-A636-D1B3E5F14173 Q33799438-37A4CB2A-DED2-4477-80DE-C6D77BA72E7C Q34546151-003F3F89-0488-485D-BAFC-BEAFE1ECE8DD Q34645331-99B16A19-5494-457D-8D60-55B9D9C04CEA Q35008535-A64D51C5-5C0D-493B-A111-C166E2CF1819 Q35598113-3B6DEEAD-3E38-48F9-AA1F-6BDACCE294EA Q35812347-89128347-F8B6-43B1-8FB9-9E6E72314CA0 Q35950841-449AF2CF-C114-400E-9467-E33F6B8CCA42 Q36230877-363A92C9-07F2-4F35-B764-63BEAD14BD01 Q36508875-5E1BDDAA-468B-4258-8793-31A55FC9E116 Q37862381-9E9EF6EC-BA9B-4C2A-A08C-98763CD163C6 Q37900368-4CDA4865-C46E-4BE2-936E-C0ACC1DA6E41 Q37903941-6C48B57D-0D88-40A4-9DF8-4221EFCA1474 Q38866016-6FD8247B-054E-43BD-BE29-CA154711A820 Q41006227-24522A42-4340-44AF-B366-4AECB47EB539 Q41303350-3D10E706-9CB1-48D4-A238-1FF74ED75ED2 Q41834766-EDBE23A1-EC31-4F93-9B3B-35F9A884555D Q42200252-136F1027-7755-4335-B583-D56B8C2D7990 Q44727099-5A9CE473-CF3B-47BF-937B-734D719D9F4C Q44952814-7A723652-6F2B-45ED-B88E-7287AC9739A4 Q46598590-78631A94-94E9-4A0B-9CCC-2D84B65172F3 Q47985355-C307A6DB-EDCE-408A-A26F-7C49F96A24C8

P2860

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

http://www.wikidata.org/entity/Q27632583

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@ast

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@en

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@nl

type

label

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@ast

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@en

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@nl

prefLabel

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@ast

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@en

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@nl

P1433

Q27632583-4E32ABEC-53CD-4710-ADC8-AD9CE417D145

P1476

Q27632583-304128A5-A8EA-455E-B450-883265D5006F

P2093

Q27632583-33C32AD8-14B5-440A-8ACB-AF0CFE316FB3

Q27632583-3509E858-C039-4F17-B16D-D25055B86945

Q27632583-62896200-38CB-4D9E-8F5D-AF148D63CC06

Q27632583-9A978785-02BA-4ABC-845A-FF1C5EA5F677

P2860

Q27632583-0DB733D3-32C6-4EF5-B780-E5AE83D3B3EF

Q27632583-0DFF0C98-A82F-48F8-8705-C7D6BB52BC7A

Q27632583-13A5E065-22D8-437D-8424-233CC8786CAD

Q27632583-1742781D-AFF4-4EB7-906E-14620BB60DFD

Q27632583-1F06A25B-100D-4AD9-A695-E18171756427

Q27632583-2742A33A-207A-4EF3-9BFD-56CDBABA733E

Q27632583-41580ED8-9AD8-410A-B1E0-C7A67AD25D09

Q27632583-6B9B71FF-0F16-493B-90B5-D922A791C4A0

Q27632583-6D7A8D55-5AF1-4EA7-9D8B-3AB1C30D4CBB

Q27632583-7C5A5B0F-BA1D-428A-9589-E2A6FEC13B44

P304

Q27632583-E7F273D8-326F-4C8A-82B3-81F5C4A4F0C3

P31

Q27632583-B2012D95-39FB-45B4-AA71-F74AEBC79A4F

P3181

Q27632583-71DFF4B4-0B1F-4BD3-AF90-0F9EEF56609D

P356

Q27632583-928EDAD0-83D8-4AD4-845C-9BBD468F609B

P407

Q27632583-324B8D3D-BA55-4B5F-9357-68C65D16B0A4

P433

Q27632583-B057A029-E210-4DE8-A6E9-EB68F846B3ED

P478

Q27632583-8B880BCF-9D27-4095-92A0-31AA58F57622

P577

Q27632583-C32154A6-E71E-46D2-B224-1506AE0386DB

P5875

Q27632583-5663A65D-4ABA-4DEE-B7D3-7D8FA369B378

P698

Q27632583-8D9C57B2-9FEC-4FC3-AABE-5A41DA971368

P921

Q27632583-3598F725-EB45-45FC-BAF1-CE041417AFED

Q27632583-803F08D6-B2B4-4ACD-A94B-45649EEB262B

Q27632583-B7B6478C-D6A2-4092-B664-F9BE2A1F758B

P932

Q27632583-BADF2476-EF49-4D54-9E72-22C57D6CD765

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

@en

P2093

H Atoda

http://www.w3.org/2001/XMLSchema#string

H Mizuno

http://www.w3.org/2001/XMLSchema#string

T Morita

http://www.w3.org/2001/XMLSchema#string

Z Fujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B

3D domain swapping: a mechanism for oligomer assembly

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Processing of X-ray diffraction data collected in oscillation mode

Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region

Peptide exosite inhibitors of factor VIIa as anticoagulants

Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX

Structure of human des(1-45) factor Xa at 2.2 A resolution

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains

P304

7230-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1584478

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.131179698

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11936205

http://www.w3.org/2001/XMLSchema#string

P698

11404471

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

protein structure

crystal structure

P932

34651

http://www.w3.org/2001/XMLSchema#string